Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY)

242 filings reported holding RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) has 204 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 170,987,354 shares of 171,717,172 outstanding shares and own 99.57% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (27,904,963 shares), BlackRock, Inc. (13,954,486 shares), Point72 Asset Management, L.P. (13,445,704 shares), Commodore Capital LP (13,350,000 shares), Casdin Capital, LLC (11,398,574 shares), VANGUARD GROUP INC (9,379,851 shares), Bellevue Group AG (8,230,870 shares), TANG CAPITAL MANAGEMENT LLC (8,068,058 shares), STATE STREET CORP (5,202,791 shares), and JPMORGAN CHASE & CO (4,338,403 shares).
This table shows the top 204 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.